Home > Healthcare > Medical Devices > Therapeutic Devices > Renal Denervation Market

Renal Denervation Market Share

  • Report ID: GMI12780
  • Published Date: Dec 2024
  • Report Format: PDF

Renal Denervation Market Share

Key industry developments in the market include the continuous advancements in device technologies. Medtronic's Symplicity Spyral has received significant FDA approvals, establishing itself as a leader in the field. New innovations such as ultrasound-based devices from ReCor Medical and the ongoing clinical trials, including the SPYRAL HTN, have expanded the clinical applicability of renal denervation systems. Strategic partnerships between major players, such as the collaboration between Venus Medtech and Healium, further support market growth. Additionally, regulatory approvals in key markets are streamlining access to these technologies.
 

Renal Denervation Market Companies

Prominent players operating in the renal denervation industry include:

  • Abbott
  • ABLATIVE SOLUTIONS
  • Boston Scientific
  • Johnson & Johnson
  • Medtronic
  • Otsuka
  • Recor
  • Symple Surgical
  • TERUMO
  • VENUS MEDTECH
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global renal denervation industry was valued at USD 1.1 billion in 2024 and is projected to grow at a 28% CAGR from 2025 to 2034, driven by the increasing prevalence of hypertension and advancements in minimally invasive medical technologies.

The U.S. renal denervation market was valued at USD 407.2 million in 2024 and is expected to grow at a 26.6% CAGR from 2025 to 2034, supported by rising hypertension-related healthcare costs and innovative clinical trials conducted by leading institutions.

Renal denervation is gaining traction in the U.S. due to increasing hypertension-related healthcare costs, active clinical trials by institutions like the Mayo Clinic, and supportive reimbursement policies for cardiovascular health programs.

Key players in the renal denervation industry include Abbott, ABLATIVE SOLUTIONS, Boston Scientific, Johnson & Johnson, Medtronic, Otsuka, Recor, Symple Surgical, TERUMO, and VENUS MEDTECH.

Renal Denervation Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 10
  • Tables & Figures: 149
  • Countries covered: 19
  • Pages: 130
 Download Free Sample